Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Ventricular Remodeling D020257 28 associated lipids
Gliosis D005911 6 associated lipids
Neuralgia D009437 28 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Amnesia D000647 12 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Sneezing D012912 6 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Liver Failure D017093 5 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Helicobacter Infections D016481 21 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Mucositis D052016 7 associated lipids
Ileitis D007079 2 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Ozaki Y et al. Potentiation of neutrophil biosynthesis of platelet-activating factor by cytochalasin B: evaluation of acetyltransferase activity. 1987 Nippon Ketsueki Gakkai Zasshi pmid:3687329
Ponpipom MM et al. Structure-activity relationships of kadsurenone analogues. 1987 J. Med. Chem. pmid:3027330
Hecker G et al. Potent inhibition of PAF-stimulated human platelets and polymorphonuclear leukocytes by the PGE1 analog OP-1206. 1987 Prog. Clin. Biol. Res. pmid:2444988
Desquand S et al. Interference of the PAF-acether antagonist BN 52021 with anaphylaxis in the guinea pig. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2445183
Kurosawa M Effect of platelet activating factor on histamine release from rat mast cells. 1987 Agents Actions Suppl. pmid:2445185
Gerard NP Characterization of substance P contractile activity on isolated guinea pig lung tissues. 1987 J. Pharmacol. Exp. Ther. pmid:2447271
Beijer L et al. The involvement of platelet activating factor in endotoxin-induced pulmonary platelet recruitment in the guinea-pig. 1987 Br. J. Pharmacol. pmid:2447993
Belch JJ et al. Whole blood white cell aggregation: a novel technique. 1987 Thromb. Res. pmid:2448894
Hannun YA et al. Sphingosine inhibition of agonist-dependent secretion and activation of human platelets implies that protein kinase C is a necessary and common event of the signal transduction pathways. 1987 J. Biol. Chem. pmid:3115982
Martin TR et al. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage. 1987 J. Clin. Invest. pmid:2821074
Rylander R and Beijer L Inhalation of endotoxin stimulates alveolar macrophage production of platelet-activating factor. 1987 Am. Rev. Respir. Dis. pmid:3541718
Dejana E et al. Modulation of endothelial cell functions by different molecular species of interleukin 1. 1987 Blood pmid:3542082
Miwa M et al. Occurrence of an endogenous inhibitor of platelet-activating factor in rat liver. 1987 J. Biol. Chem. pmid:3804997
Sugiura T et al. Transacylation of lyso platelet-activating factor and other lysophospholipids by macrophage microsomes. Distinct donor and acceptor selectivities. 1987 J. Biol. Chem. pmid:3805017
Sturk A et al. Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis. 1987 J. Clin. Invest. pmid:3805272
Argyroudi-Akoyunoglou JH and Vakirtzi-Lemonias C Low-temperature fluorescence emission changes in thylakoids induced by acetyl glyceryl ether phosphorylcholine (AGEPC). 1987 Arch. Biochem. Biophys. pmid:3813566
Maguire MH and Csonka-Khalifah L Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs. 1987 Biochim. Biophys. Acta pmid:3117116
Blache D and Ciavatti M Rat platelet arachidonate metabolism in the presence of Ca2+, Sr2+ and Ba2+: studies using intact platelets and semi-purified phospholipase A2. 1987 Biochim. Biophys. Acta pmid:2444263
Brunelleschi S et al. Platelet-activating factor-acether-induced relaxation of guinea pig airway muscle: role of prostaglandin E2 and the epithelium. 1987 J. Pharmacol. Exp. Ther. pmid:3478474
Casals-Stenzel J Triazolodiazepines are potent antagonists of platelet activating factor (PAF) in vitro and in vivo. 1987 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3587377
Brambilla A et al. WEB 2086. A potent PAF antagonist exerts protective effect toward PAF-induced gastric damage. 1987 Pharmacol Res Commun pmid:3588650
Jancar S et al. Comparative effects of platelet activating factor, leukotriene D4 and histamine on guinea pig trachea, bronchus and lung parenchyma. 1987 Prostaglandins pmid:3588970
Malo PE et al. Enhancement of leukotriene D4-induced contraction of guinea-pig isolated trachea by platelet activating factor. 1987 Prostaglandins pmid:3588971
Joseph R et al. Sensitivity to PAF is increased in migraine patients. 1987 Thromb. Haemost. pmid:3590077
Valone FH Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers. 1987 Thromb. Res. pmid:3590086
Tokumura A et al. Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists. 1987 Thromb. Res. pmid:3590110
Christman BW et al. Effect of platelet-activating factor on aerosol histamine responsiveness in awake sheep. 1987 Am. Rev. Respir. Dis. pmid:3592402
Benveniste J A role for paf-acether (platelet-activating factor) in bronchial hyperreactivity? 1987 Am. Rev. Respir. Dis. pmid:3592414
Sugatani J et al. Platelet-activating factor stimulation of rabbit platelets is blocked by serine protease inhibitor (chymotryptic protease inhibitor). 1987 J. Biol. Chem. pmid:3106343
Ramesha CS and Pickett WC Fatty acid composition of diacyl, alkylacyl, and alkenylacyl phospholipids of control and arachidonate-depleted rat polymorphonuclear leukocytes. 1987 J. Lipid Res. pmid:3106551
Dallob A et al. Pharmacological evidence for a role of lipoxygenase products in platelet-activating factor (PAF)-induced hyperalgesia. 1987 Biochem. Pharmacol. pmid:2822047
Coëffier E et al. Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils. 1987 Br. J. Pharmacol. pmid:3118996
Shigenobu K et al. Potentiation by bovine serum albumin (BSA) of endothelium-dependent vasodilator response to acetyl glyceryl ether phosphorylcholine (AGEPC). 1987 J. Pharmacobio-dyn. pmid:3625454
Hirafuji M et al. Regulation of PAF-acether (platelet-activating factor) biosynthesis in cultured human vascular endothelial cells stimulated with thrombin. 1987 Biochim. Biophys. Acta pmid:2888488
Jensen NJ et al. FAB MS/MS for phosphatidylinositol, -glycerol, -ethanolamine and other complex phospholipids. 1987 Lipids pmid:3626775
Cox CP and Wood KL Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam. 1987 Thromb. Res. pmid:3629553
Ostermann G et al. Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor. 1987 Thromb. Res. pmid:3629555
Pettipher ER et al. PAF-acether in chronic arthritis. 1987 Agents Actions pmid:3630862
Stenmark KR et al. Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia. 1987 Am. Rev. Respir. Dis. pmid:3631747
O'Donnell SR and Barnett CJ Microvascular leakage to platelet activating factor in guinea-pig trachea and bronchi. 1987 Eur. J. Pharmacol. pmid:3040440
Nakamura T et al. Platelet-activating factor in late asthmatic response. 1987 Int. Arch. Allergy Appl. Immunol. pmid:3804454
Ramesha CS and Pickett WC Species-specific variations in the molecular heterogeneity of the platelet-activating factor. 1987 J. Immunol. pmid:3100641
Beauvais F and Benveniste J [IgE and anaphylaxis mediators]. 1987 Allerg Immunol (Paris) pmid:2968802
Patrignani P et al. Platelet-activating factor (PAF) receptor antagonists inhibit mitogen-induced human peripheral blood T-cell proliferation. 1987 Biochem. Biophys. Res. Commun. pmid:2825672
Schwertschlag U et al. L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney. 1987 Circ. Res. pmid:3297384
O'Flaherty JT and Nishihira J Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils. 1987 J. Immunol. pmid:3029224
Page CP A role for platelet activating factor and platelets in the induction of bronchial hyperreactivity. 1987 Int J Tissue React pmid:3298115
Lian EC Pathogenesis of thrombotic thrombocytopenic purpura. 1987 Semin. Hematol. pmid:3299722
Camussi G et al. Release of platelet-activating factor from rabbit heart perfused in vitro by sera with transplantation alloantibodies. 1987 Transplantation pmid:3299910
Zimmerman GA et al. Production of platelet-activating factor, a biologically active lipid, by vascular endothelial cells. 1987 Am. Rev. Respir. Dis. pmid:3300444
Henderson WR Lipid-derived and other chemical mediators of inflammation in the lung. 1987 J. Allergy Clin. Immunol. pmid:3031147
Lecrubier C et al. [Platelet aggregation tests in 26 cases of heparin-induced thrombopenia. Methodological, diagnostic problems and therapeutic aspects]. 1987 J Mal Vasc pmid:2834484
Caramelo C et al. Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver. 1987 Eur. J. Clin. Invest. pmid:3106053
Matsumoto T et al. G-protein dissociation, GTP-GDP exchange and GTPase activity in control and PMA treated neutrophils stimulated by fMet-Leu-Phe. 1987 Biochem. Biophys. Res. Commun. pmid:3032170
Piper PJ and Stewart AG Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists. 1987 Br. J. Pharmacol. pmid:3034369
Hwang SB Specific receptor sites for platelet activating factor on rat liver plasma membranes. 1987 Arch. Biochem. Biophys. pmid:2821908
Shimizu K et al. [Actions of platelet activating factor in pulmonary circulation--experimental investigation using rabbit blood vessel smooth muscle preparations]. 1987 Nihon Kyobu Shikkan Gakkai Zasshi pmid:3444152
Lagente V et al. Platelet-activating factor (PAF-acether) and microcirculation: effect of Lyso-PAF and PAF-antagonists. 1987 Braz. J. Med. Biol. Res. pmid:3452452
Robaut C et al. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets. 1987 Biochem. Pharmacol. pmid:2822048
Gentry PA et al. Inhibitory effect of trichothecene mycotoxins on bovine platelets stimulated by platelet activating factor. 1987 Can. J. Vet. Res. pmid:3453270
Dale MM and Penfield A Comparison of the effects of indomethacin, RHC80267 and R59022 on superoxide production by 1,oleoyl-2,acetyl glycerol and A23187 in human neutrophils. 1987 Br. J. Pharmacol. pmid:2822195
Livio M et al. A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2823570
Stenzel H et al. Effect of the PAF-antagonist SRI 63-441 on the allergic reaction in awake dogs with natural asthma. 1987 Agents Actions Suppl. pmid:2823582
Hartiala KT et al. Lack of correlation between calcium mobilization and respiratory burst activation induced by chemotactic factors in rabbit polymorphonuclear leukocytes. 1987 Biochem. Biophys. Res. Commun. pmid:3034265
O'Flaherty JT and Wykle RL Metabolic origin and fate of platelet-activating factor. 1987 Agents Actions Suppl. pmid:2823583
Krishnamurthi S et al. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA. 1987 Biochim. Biophys. Acta pmid:3101746
Carlson RP et al. Pharmacologic modulation of PAF-induced mortality in mice. 1987 Agents Actions pmid:3120513
Bussolino F et al. Studies on the mechanism of interleukin 1 stimulation of platelet activating factor synthesis in human endothelial cells in culture. 1987 Biochim. Biophys. Acta pmid:3024738
Sweatt JD et al. Evidence for a role for Na+-H+ exchange in activation of human platelets by PAF. 1987 Circ. Res. pmid:2822286
Kurgan J [Blood platelets and asthma and other lung diseases]. 1987 Pol Tyg Lek pmid:3684765
Ezra D et al. Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig. 1987 Prostaglandins pmid:3685397
Liu BN [Neoplastic membrane-toxic activity as one of the pathogenetic factors in blood cell and tumor growth changes]. 1987 Jan-Feb Patol Fiziol Eksp Ter pmid:3550649
Lurie A et al. Exercise- and allergen-induced asthma do not change the production of Paf-acether by neutrophils and platelets. 1987 Jul-Aug Bull Eur Physiopathol Respir pmid:3690021
Auriault C et al. The effector function of platelets is induced and regulated by T lymphocytes. 1987 Jul-Aug Ann. Inst. Pasteur Immunol. pmid:3118905
Fiedler VB et al. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs. 1987 Mar-Apr Basic Res. Cardiol. pmid:3606544
Arnoux B et al. Antigenic release of paf-acether and beta-glucuronidase from alveolar macrophages of asthmatics. 1987 Mar-Apr Bull Eur Physiopathol Respir pmid:3607326
Berdel WE et al. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro. 1987 Nov-Dec Anticancer Res. pmid:3442414
Lakin KM et al. [Action of calcium antagonists on thrombocyte aggregation]. 1987 Sep-Oct Farmakol Toksikol pmid:2826225
Frick KK et al. Platelet-derived growth factor-induced c-myc RNA expression. Analysis of an inducible pathway independent of protein kinase C. 1988 J. Biol. Chem. pmid:2449430
Dillon PK and Durán WN Effect of platelet-activating factor on microvascular permselectivity: dose-response relations and pathways of action in the hamster cheek pouch microcirculation. 1988 Circ. Res. pmid:2450695
Ferrell JE et al. Membrane bilayer balance and platelet shape: morphological and biochemical responses to amphipathic compounds. 1988 Biochim. Biophys. Acta pmid:3355815
Csatò M and Czarnetzki BM Effect of BN 52021, a platelet activating factor antagonist, on experimental murine contact dermatitis. 1988 Br. J. Dermatol. pmid:3377969
Hoffman DR et al. Platelet-activating factor induces glycogen degradation in fetal rabbit lung in utero. 1988 J. Biol. Chem. pmid:3379072
Kertscher HP et al. [Synthesis and thrombocyte-aggregating action of a structural analog of platelet activating factor with a modified head group]. 1988 Pharmazie pmid:3380866
Hirafuji M et al. Transient increase of cytosolic free calcium in cultured human vascular endothelial cells by platelet-activating factor. 1988 Biochem. Biophys. Res. Commun. pmid:3408504
Stahl GL et al. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock. 1988 Eur. J. Pharmacol. pmid:3409951
Pretolani M et al. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection. 1988 Am. Rev. Respir. Dis. pmid:3202509
Adamus WS et al. Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation. 1988 Eur. J. Clin. Pharmacol. pmid:3181277
Yanoshita R et al. Hydrolysis of platelet activating factor and its methylated analogs by acetylhydrolases. 1988 J. Biochem. pmid:3182751
Suzuki Y et al. Release of acetylhydrolase from platelets on aggregation with platelet-activating factor. 1988 Eur. J. Biochem. pmid:3345757
Benveniste J and Leyravaud S Retention of platelet activating factor by human neutrophils. 1988 J. Immunol. pmid:3346547
Kimani G et al. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor. 1988 J. Immunol. pmid:3361129
Robertson DA et al. Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity. 1988 J. Pharmacol. Exp. Ther. pmid:3361438
Egger M et al. Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release. 1988 Biochim. Biophys. Acta pmid:3143424
Pitcock JA Morphometric studies of the renomedullary interstitial cells. 1988 Am. J. Med. Sci. pmid:3284348
Plante GE et al. Platelet activating factor antagonism with BN52021 protects the kidney against acute ischemic injury. 1988 Prostaglandins Leukot. Essent. Fatty Acids pmid:3231663
Santos JC et al. Effect of intrarenal infusion of synthetic PAF-acether in dogs. 1988 Rev. Esp. Fisiol. pmid:3231880
Croft KD et al. The effect of dietary fish oil and long-term salt loading on blood pressure and eicosanoid metabolism in spontaneously hypertensive rats. 1988 Clin. Exp. Pharmacol. Physiol. pmid:3271614
Valone FH Interrelationships among platelet-activating factor binding and metabolism and induction of platelet activation. 1988 Prog. Clin. Biol. Res. pmid:2850575
Shukla SD and Morrison WJ Platelet activating factor receptor occupancy in relation to activation and desensitization of phosphoinositide specific phospholipase C. 1988 Prog. Clin. Biol. Res. pmid:2850576